Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01060020 · ClinicalTrials.gov registry record · Phase 4

Acute Hemodynamic Effects of Sildenafil in Patients With Severe Aortic Stenosis

A Phase 4 study, sponsored by Washington University School of Medicine.

Completed
Registry status
Phase 4
Development phase
20
Enrollment target

NCT01060020: Completed Phase 4 study, sponsored by Washington University School of Medicine.

NCT01060020 is a Phase 4 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01060020, a Phase 4 study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
Phase 4
Development phase
20 participants
Enrollment target

Study Summary

Pulmonary hypertension is common in patients with aortic stenosis and is associated with worse operative and long-term outcomes. Sildenafil has been shown to reduce pulmonary artery pressure and improve exercise performance in patients with left-sided heart failure, but this has not been tested in patients with aortic stenosis. We hypothesize that Sildenafil will produce a clinically significant decrease in pulmonary artery pressure in patients with severe aortic stenosis. The dose of Sildenafil that produces a significant decrease in pulmonary artery pressure will be safe and well tolerated in patients with and without a depressed ejection fraction.

Interventions

  • DRUG Sildenafil

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2010-01
Est. Completion 2011-10
Phase Phase 4

What the finished NCT01060020 record still lists

NCT01060020 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Sildenafil is the first listed.

NCT01060020 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01060020 about?

NCT01060020 is a clinical study titled "Acute Hemodynamic Effects of Sildenafil in Patients With Severe Aortic Stenosis". Pulmonary hypertension is common in patients with aortic stenosis and is associated with worse operative and long-term outcomes. Sildenafil has been shown to reduce pulmonary artery pressure and improve exercise performance in patients with left-sided heart failure, but this has not been tested in p...

What is the current status of trial NCT01060020?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2010-01. Estimated completion is 2011-10.

What interventions are being tested in trial NCT01060020?

The interventions under investigation include: Sildenafil (DRUG).

Who is sponsoring clinical trial NCT01060020?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01060020's enrollment target sits among peer trials

20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01060020, the US trial registry maintained by the National Library of Medicine. NCT01060020 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.